NCT01925261View on ClinicalTrials.gov

A Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Knee Osteoarthritis
Interventions
DRUG

TPX-100 50mg

DRUG

TPX-100 100mg

DRUG

TPX-100 200mg

DRUG

TPX-100 20mg

DRUG

Placebo

Trial Locations (1)

Unknown

C3 Clinical Research Associates, Seattle

Sponsors

Lead Sponsor

OrthoTrophix, Inc
All Listed Sponsors
lead

OrthoTrophix, Inc

INDUSTRY

NCT01925261 - A Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees | Biotech Hunter | Biotech Hunter